Development of a continuous assay for the measurement of tissue factor procoagulant activity on intact cells

Laboratory Investigation

Volumn 90, Issue 6, 2010, Pages 953-962

  Caldwell, Jennifer A ^a   Dickhout, Jeffrey G ^a   Al Hashimi, Ali A ^a   Austin, Richard C ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Chromogenic assay; Encryption; Enzyme kinetics; Thrombosis; Tissue factor

Indexed keywords

ENZYME INHIBITOR; THAPSIGARGIN; THROMBOPLASTIN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BLADDER TUMOR; CARCINOMA; CELL FUNCTION; CELL SURVIVAL; DRUG EFFECT; ENDOPLASMIC RETICULUM; HUMAN; IMMUNOBLOTTING; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA; CELL LINE, TUMOR; CELL PHYSIOLOGICAL PHENOMENA; CELL SURVIVAL; ENDOPLASMIC RETICULUM; ENZYME INHIBITORS; HUMANS; IMMUNOBLOTTING; NEOPLASM PROTEINS; THAPSIGARGIN; THROMBOPLASTIN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77954578563     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.59     Document Type: Article

References (25)

1. Carson SD, Brozna JP. The role of tissue factor in the production of thrombin. Blood Coagul Fibrinolysis 1993;4:281-292.
2. van der Wal AC, Li X, de Boer OJ. Tissue factor expression in the morphologic spectrum of vulnerable atherosclerotic plaques. Semin Thromb Hemost 2006;32:40-47.
3. Berg JM, Tymoczko JL, Stryer L. Biochemistry, 5th edn. WH Freeman and Company: New York, 2002.
4. Gailani D, Renne T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol 2007;27:2507-2513.
5. Rock G, Wells P. New concepts in coagulation. Crit Rev Clin Lab Sci 1997;34:475-501.
6. Bach R, Rifkin DB. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci USA 1990;87: 6995-6999.
7. Carson SD. Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane. Blood Coagul Fibrinolysis 1996;7:303-313.
8. Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood 1997;89:3270-3276.
9. Penn MS, Cui MZ, Winokur AL, et al. Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation. Blood 2000;96:3056-3063.
10. Drake TA, Ruf W, Morrissey JH, et al. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 1989;109:389-395.
11. Kunzelmann-Marche C, Satta N, Toti F, et al. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface. Thromb Haemost 2000;83:282-289.
12. Iakhiaev A, Pendurthi UR, Voigt J, et al. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor. J Biol Chem 1999;274:36995-37003.
13. Roy S, Paborsky LR, Vehar GA. Self-association of tissue factor as revealed by chemical crosslinking. J Biol Chem 1991;266: 4665-4668.
14. Egorina EM, Sovershaev MA, Osterud B. Regulation of tissue factor procoagulant activity by post-translational modifications. Thromb Res 2008;122:831-837.
15. Watson LM, Chan AK, Berry LR, et al. Overexpression of the 78-kDa glucose-regulated protein/immunoglobulin-binding protein (GRP78/BiP) inhibits tissue factor procoagulant activity. J Biol Chem 2003;278:17438-17447.
16. Osterud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes. J Leukoc Biol 1992;51:462-465.
17. Sovershaev MA, Egorina EM, Gruber FX, et al. High tissue factorexpressing human monocytes carry low surface CD36: application to intersubject variability. J Thromb Haemost 2007;5:2453-2460.
18. Grotjan HE, Keel BA. Data interpretation and quality control. In: Diamandis EP, Christopoulos TK (eds). Immunoassay, 1st edn. Academic Press: Toronto, 1996.
19. Gonzalez-Gronow M, Cuchacovich M, Llanos C, et al. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucoseregulated protein 78 isolated from patient serum. Cancer Res 2006;66:11424-11431.
20. Carson SD, Archer PG. Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reader. Thromb Res 1986;41:185-195.
21. Carson SD. Computerized analysis of enzyme cascade reactions using continuous rate data obtained with an ELISA reader. Comput Programs Biomed 1985;19:151-157.
22. Kosow DP, Furie B, Forastieri H. Activation of factor X: kinetic properties of the reaction. Thromb Res 1974;4:219-227.
23. Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006;26:456-461.
24. Carson SD, Bromberg ME. Tissue factor encryption/de-encryption is not altered in the absence of the cytoplasmic domain. Thromb Haemost 2000;84:657-663.
25. Bikfalvi A, Beress L. Natural proteinase inhibitors: blood coagulation inhibition and evolutionary relationships. Comp Biochem Physiol B 1987;87:435-441.